Patent · US Active

Triazolopyridine compounds, compositions and methods of use thereof

US9873709B2 · kind B2 · utility

1Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2017
Grant dateJan 23, 2018
Priority date—
Expiry dateApr 27, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula 0, Formula I and Formula II and methods of use as Janus kinase inhibitors are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.